Psychiatry Research: Neuroimaging
Volume 162, Issue 2 , Pages 113-121, 28 February 2008

Metabolic alterations in medication-free patients with bipolar disorder: A 3T CSF-corrected magnetic resonance spectroscopic imaging study

  • John D. Port

      Affiliations

    • Department of Radiology (Mayo E2A), Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 507 538 0348; fax: +1 507 284 1554
  • ,
  • Sencan S. Unal

      Affiliations

    • Department of Psychiatry, Mayo Clinic, Rochester, MN, USA
  • ,
  • David A. Mrazek

      Affiliations

    • Department of Psychiatry, Mayo Clinic, Rochester, MN, USA
  • ,
  • Susan M. Marcus

      Affiliations

    • Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA

Received 28 March 2006; received in revised form 5 July 2007; accepted 6 August 2007.

Abstract 

The objective of this study was to determine whether cerebrospinal fluid(CSF)-corrected concentrations of N-acetylaspartate are lower in several brain regions of drug- and medication-free subjects with bipolar disorder as compared with matched healthy controls. Bipolar subjects (n=21) and age- and sex-matched healthy control (n=21) were studied using proton magnetic resonance spectroscopic imaging on a 3T magnetic resonance (MR) scanner. Spectra were quantified using the LCModel, and metabolite values were CSF-corrected to yield metabolite concentrations. Fourteen regions of interest and five metabolite concentrations in each subject were selected for statistical analysis. We found that bipolar subjects had significantly decreased N-acetylaspartate concentrations in both caudate heads and the left lentiform nucleus. Choline and creatine in the head of the right caudate were also significantly decreased in bipolar subjects. Significantly increased myo-inositol was found in the left caudate head in bipolar subjects. Bipolar subjects showed significantly decreased glutamate/glutamine concentrations in the frontal white matter bilaterally and in the right lentiform nucleus. No differences were found for other metabolites examined. These preliminary findings suggest decreased neuronal density or viability in the basal ganglia and neurometabolic abnormalities in the frontal lobes of subjects with bipolar disorder.

Keywords: N-acetylaspartate, Myoinositol, Creatine, Glutamate/glutamine, Basal ganglia, Frontal lobe

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Previous presentation: Paper presented at RSNA 90th Scientific Assembly and Annual Meeting, Chicago, IL, November 27–December 3, 2004. (#SSG13-08)

PII: S0925-4927(07)00152-7

doi:10.1016/j.pscychresns.2007.08.004

Refers to corrigendum:

  • Corrigendum to “Metabolic alterations in medication-free patients with bipolar disorder: A 3T CSF-corrected magnetic resonance spectroscopic imaging study” [Psychiatry Research: Neuroimaging 162(2) (2008) 113–121]

    John D. Port, Sencan S. Unal, David A. Mrazek, Susan M. Marcus
    Psychiatry Research: Neuroimaging 30 October 2008 (Vol. 164, Issue 1, Page 95)

Psychiatry Research: Neuroimaging
Volume 162, Issue 2 , Pages 113-121, 28 February 2008